What’s Behind the Persistent Shortage of Lifesaving EpiPens

Bookmark
(Bloomberg) -- Mylan NV and Pfizer Inc. are still struggling with manufacturing issues for the EpiPen anti-allergy injector as the critical back-to-school season gets underway and a rival generic p...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.